Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Areej Al Rabea"'
Autor:
Richard S. Fraser, Areej Al-Rabea, Jan Seuntjens, Bassam Abdulkarim, Ayman Oweida, Mojgan Ebrahimi, Russel Ruo, Siham Sabri
Publikováno v:
Oncotarget
Stereotactic ablative radiotherapy (SABR) is the main treatment for inoperable early-stage non-small cell lung cancer (NSCLC). Despite the widespread use of SABR, the biological determinants of response to SABR remain poorly investigated. We develope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46079a98d63b825c1d4c7ca26b760fe2
https://doi.org/10.18632/oncotarget.22727
https://doi.org/10.18632/oncotarget.22727
Autor:
Vikrant K Bhosle, José Carlos Rivera, Tianwei Zhou, Samy Omri, Melanie Sanchez, David Hamel, Tang Zhu, Raphael Rouget, Areej Al Rabea, Xin Hou, Isabelle Lahaie, Alfredo Ribeiro-da-Silva, Sylvain Chemtob
Publikováno v:
Cell Discovery. 2
Correction to: Cell Discovery (2016) 2, 16017; doi:10.1038/celldisc.2016.17; published online 12 July 2016 In the initial publication of this article, the abbreviation of the first author’s name in citation ‘K Bhosle V’ was incorrect, which sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4c5224031bdc47b228c3abad2fa26db
https://doi.org/10.1038/celldisc.2016.34
https://doi.org/10.1038/celldisc.2016.34
Autor:
Brian M. Meehan, Bassam Abdulkarim, Janusz Rak, Siham Sabri, Areej Al Rabea, Chaitanya Nirodi, Paul Daniel
Publikováno v:
Cancer Research. 78:4174-4174
Background: ablative radiation therapy (ABR) serves as the treatment of choice for early stage non-small cell lung cancer (NSCLC) patients who are not surgical candidates. NSCLC patients with mutations in the tyrosine kinase domain (TKD) of the epide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63f62e997a8ad25c1c72ce7f3f922407
https://doi.org/10.1158/1538-7445.am2018-4174
https://doi.org/10.1158/1538-7445.am2018-4174
Autor:
Mélanie Sanchez, Alfredo Ribeiro-da-Silva, José Carlos Rivera, Raphael Rouget, David Hamel, Tang Zhu, Isabelle Lahaie, Tianwei Ellen Zhou, Xin Hou, Sylvain Chemtob, Vikrant K. Bhosle, Areej Al Rabea, Samy Omri
Publikováno v:
Cell Discovery
Platelet-activating factor (PAF) is a pleiotropic phospholipid with proinflammatory, procoagulant and angiogenic actions on the vasculature. We and others have reported the presence of PAF receptor (Ptafr) at intracellular sites such as the nucleus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af90c64942f609f6d3d13b8d4d44cc8d
http://europepmc.org/articles/PMC4941644
http://europepmc.org/articles/PMC4941644
Publikováno v:
Journal of Reproductive Immunology. 112:81
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eecd2600bda466b9660172142d6c8cd4
https://doi.org/10.1016/j.jri.2015.08.004
https://doi.org/10.1016/j.jri.2015.08.004